Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at ...

ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to ...

STOCKHOLM, SE / ACCESS Newswire / January 12, 2026 / iZafe Group (STO:IZAFE-B) - As we summarize December and at the same time leave 2025 behind, it is clear that the year has been one of the most ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor ...

Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases ...

Company now expects to complete enrollment of 150 patients in Q2 2026, with a Phase 3 data readout in mid-2027; Rolling NDA ...

Genialis Expressions empowers drug development teams to make confident decisions by unifying workflows and standardizing omics data for enterprise-grade clarity and comparability across studiesBOSTON ...

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader in circulating tumour cell (CTC) intelligence, with tests and services supporting research, drug ...

Guests had an opportunity to meet Gabby Thomas, win health-focused prizes, and learn simple ways to take a more active role ...

Study met its primary endpoint demonstrating safety and tolerability of CMTX-101 in people with cystic fibrosisCMTX-101 ...

Consistent national recognition reflects a culture where employees thrive and patients benefit PALM SPRINGS, CALIFORNIA / ...

Asahi Kasei announced that ZOLL® Medical, an Asahi Kasei company, has launched the next-generation LifeVest® wearable ...